Article citationsMore>>
Y. Yu, Q. Lang, Z. Chen, B. Li, C. Q. Yu, D. Z. Zhu, X. F. Zhai and C. Q. Ling, “The Efficacy for Unresectable Hepatocellular Carcinoma May Be Improved by Transcatheter Arterial Chemoembolization in Combination with a Traditional Chinese Herbal Medicine Formula: A Retrospective Study,” Cancer, Vol. 115, No. 22, 2009, pp. 5132-5138. http://dx.doi.org/10.1002/cncr.24567
has been cited by the following article:
-
TITLE:
Liver Cancer: Zheng Classification of Qi Stagnation and Blood Stasis
AUTHORS:
Yongsong Guan, Qing He
KEYWORDS:
Chinese Traditional Medicine; Syndrome; Liver Cancer
JOURNAL NAME:
Pharmacology & Pharmacy,
Vol.5 No.1,
January
16,
2014
ABSTRACT: There is a long history of using traditional Chinese
medicine in the treatment of liver cancer and other malignnancies. The classification
of Qi stagnation and blood stasis (QSBS) is the most common Zheng in liver cancer.
This Zheng is frequently encountered in liver cancers falling into the pathological
category of massive type. QSBS is the principal mechanism for a tumor to develop.
Liver cancer with QSBS Zheng has characteristic clinical manifestations. Evidence
from ex vivo, in vivo and clinical studies has been reported
for the identification and management of liver cancer with QSBS Zheng. This article
reviews evidence-based study advances of QSBS Zheng, the most common Zheng encountered
in liver cancer.